You are here

antibodies

Immunovant shares surge as early antibody treatment data beats expectations

Immunovant shares surge as early antibody treatment data beats expectations

Yahoo/Reuters

clinical trials

autoimmune diseases

Flag link:

Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement

Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement

Fierce Pharma

Samsung BioLogics

Bristol Myers Squibb

drug manufacturing

Flag link:

After Catalent rumors, Danaher strikes $5.7B deal to acquire antibody specialist Abcam

After Catalent rumors, Danaher strikes $5.7B deal to acquire antibody specialist Abcam

Fierce Pharma

Flag link:

Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm

Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm

BioSpace

clinical trials

Flag link:

AstraZeneca confident new COVID antibody protects against known variants

AstraZeneca confident new COVID antibody protects against known variants

Reuters

Flag link:

FDA starts review of Sanofi, AZ antibody for RSV prevention

FDA starts review of Sanofi, AZ antibody for RSV prevention

Pharmaphorum

Flag link:

AbbVie Gains Access to Pulmonary Fibrosis Antibody with $225M DJS Buy

AbbVie Gains Access to Pulmonary Fibrosis Antibody with $225M DJS Buy

BioSpace

pulmonary fibrosis

Flag link:

Versant partners with AbCellera to arm startups with better antibodies

Versant partners with AbCellera to arm startups with better antibodies

BioPharma Dive

Versant Ventures

drug development

Flag link:

AstraZeneca picks up suite of new Covid-19 antibodies, shining spotlight on Oxford-tied startup

AstraZeneca picks up suite of new Covid-19 antibodies, shining spotlight on Oxford-tied startup

Endpoints

RQ Biotechnology

Flag link:

Astellas, Twist Join Forces to Enhance Tumor Immunity

Astellas, Twist Join Forces to Enhance Tumor Immunity

BioSpace

Twist Bioscience

Flag link:

AstraZeneca says no severe virus cases or deaths after taking antibody

AstraZeneca says no severe virus cases or deaths after taking antibody

Morningstar

Flag link:

Regeneron's bid for COVID-19 drug's full approval hits snag as FDA extends review

Regeneron's bid for COVID-19 drug's full approval hits snag as FDA extends review

Fierce Pharma

Flag link:

FDA halts Vir, GSK antibody use in response to COVID subvariant's spread

FDA halts Vir, GSK antibody use in response to COVID subvariant's spread

BioPharma Dive

Vir Biotechnology

Flag link:

First-Ever Computationally-Designed Antibody Enters Clinical Trials

First-Ever Computationally-Designed Antibody Enters Clinical Trials

BioSpace

Biolojic Design

clinical trials

Flag link:

Adagio knows its COVID-19 antibody works against old variants. Can it win EUA in the era of omicron?

Adagio knows its COVID-19 antibody works against old variants. Can it win EUA in the era of omicron?

Fierce Biotech

Adagio Therapeutics

Flag link:

Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab

Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab

BioSpace

IGM Biosciences

Flag link:

Synthetic Antibodies to be Designed with Organoids

Synthetic Antibodies to be Designed with Organoids

Science & Enterprise

synthetic antibodies

Prellis Biologics

Flag link:

Novartis backs Epsilogen's bid to turn 'Cinderella antibody' into new class of cancer drug

Novartis backs Epsilogen's bid to turn 'Cinderella antibody' into new class of cancer drug

Fierce Biotech

Flag link:

FDA bans use of Lilly, Regeneron COVID drugs due to Omicron

FDA bans use of Lilly, Regeneron COVID drugs due to Omicron

Pharmaforum

Omicron COVID-19 variant

Flag link:

GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand

GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand

Fierce Pharma

Vir Biotechnology

drug manufacturing

Samsung BioLogics

Flag link:

Pages